Henry Schein, US42548G1040

Henry Schein stock holds near a 52-week high after a Buy upgrade

Published on 08/17/2026 at 22:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Henry Schein stock is holding near its 52-week high after Wall Street Zen lifted its rating to Buy on August 17, 2026. The latest quarter showed $3.46 billion in revenue and $1.27 in EPS.

Bauhaus-Grafikposter mit geometrischen Formen in Primärfarben und zentriertem Text MEDTECH
Henry Schein US42548G1040 im Bauhaus-Stil mit geometrischen Formen und dem Sektor-Text MEDTECH, Illustration mit AI erstellt.

Henry Schein, Inc. (US42548G1040) stock opened at $89.77 and traded near its 52-week high of $92.18 on August 17, 2026, after Wall Street Zen lifted the shares to Buy from Hold. The move comes with a broader analyst view that still sits at Hold and an average price target of $92.27.

Upgrade meets steady numbers

MarketBeat said Henry Schein reported $1.27 in quarterly EPS on August 4, 2026, beating the $1.24 estimate by $0.03. Revenue reached $3.46 billion, rising 6.7% year over year from $1.10 in EPS in the same quarter of the prior year.

The current fiscal 2026 guidance calls for EPS of $5.29 to $5.39, while analysts on average are looking for $5.35 for the full year. That leaves the latest company outlook only a few cents away from the Street view.

Analysts stay split

The latest consensus data show eight Buy ratings, six Hold ratings, and one Sell rating. The spread matters because the average target of $92.27 leaves only 2.78% upside from the $89.77 opening level cited on August 17, 2026.

That setup puts the stock in a narrow band between a recent earnings beat and a valuation that already reflects much of the good news. The 200-day moving average at $79.07 and the 50-day average at $84.81 also show how far the shares have already run from earlier levels.

What Henry Schein sells

Henry Schein distributes dental, medical, and animal health products and services through its Schein Dental, Schein Medical, and Animal Health segments. The company also sells equipment, instruments, vaccines, pharmaceuticals, diagnostics, and practice technology that support office-based providers.

Share price snapshot

Henry Schein stock traded at $89.77 on August 17, 2026, with a market capitalization of $10.00 billion and a 1-year range of $61.94 to $92.18. The shares were up 18.74% for the year in the market data snapshot from August 17, 2026.

Fact box

Company: Henry Schein, Inc.
ISIN: US42548G1040
Ticker: HSIC
Exchange: Nasdaq
Price (as of August 17, 2026, 4:00 p.m. ET): $89.77 USD
Market cap: $10.00 billion (as of August 17, 2026)
Sector / Industry: Health Care / Health Care Supplies
Index membership: Russell 1000

Disclaimer...

en | US42548G1040 | HENRY SCHEIN | boerse | 69961457 | bgmi